Table 3. Risk score analysis of RCC cases and noncancer controls.
| Score | 0–0.736 | >0.736–8.235 | PPV | NPV |
|---|---|---|---|---|
| Training set | ||||
| Controls | 19 | 9 | 0.71 | 0.76 |
| RCC | 6 | 22 | ||
| Validation set | ||||
| Controls | 65 | 14 | 0.80 | 0.73 |
| RCC | 24 | 55 | ||
| Both sets | ||||
| Controls | 84 | 23 | 0.71 | 0.80 |
| Stage I RCC | 21 | 55 | ||
| Both sets | ||||
| Controls | 84 | 23 | 0.74 | 0.76 |
| Stage I–II RCC | 26 | 66 |
RCC, renal cell carcinoma; PPV, positive predictive value; NPV, negative predictive value.